| 05:49 | Genscript Biotech's Phase 3 Study for Myeloma Treatment Meets Primary Endpoint; Shares .. |  |
| 26/01 | Genscript Biotech's Multiple Myeloma Treatment Generates $55 Million in Net Trade Sales.. | |
| 25/01 | Genscript Biotech Corporation Reports Sales Results for the Quarter Ended 31 December 2.. | |
| 24/01 | Genscript Biotech Grants Restricted Shares to Non-Executive Directors | |
| 18/01 | Hillhouse-backed GenScript ProBio to raise $224 million from Legend Capital, others | |
| 18/01 | Probio Technology Limited announced that it expects to receive $224 million in funding .. | |
| 03/01 | Chinese Regulator Accepts Genscript Biotech's New Drug Application for Chimeric Antigen.. | |
| 2022 | Genscript Biotech Appoints Rotating CEO | |
| 2022 | Genscript Biotech Corporation Announces Chief Executive Officer Changes | |
| 2022 | Genscript Biotech Corporation Announces Redesignation of Dr. Zhang Fangliang from A Non.. | |
| 2022 | Cell and Gene Therapy Companies Leverage GenScript's cGMP sgRNA Capability to Accelerat.. | |
| 2022 | GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS | |
| 2022 | GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identifica.. | |
| 2022 | GenScript Biotech Corporation Partners with Allozymes to Accelerate Protein Discovery a.. | |
| 2022 | Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will furth.. | |
| 2022 | Genscript Biotech Unit Gets US FDA Nod for Clinical Development of Small Cell Lung Canc.. | |
| 2022 | GenScript Named a BioSpace 2023 Best Place to Work | |
| 2022 | Genscript Biotech to Present Data on Multiple Myeloma Therapies in US; Shares Rise 4% | |
| 2022 | GenScript Biotech Unit Gains $55 Million in Q3 Sales from Myeloma Medication; Shares Ri.. | |
| 2022 | Genscript Biotech Corporation Reports Sales Results for the Quarter Ended September 30,.. | |
| 2022 | Genscript Biotech's U.S. Unit Amends CFO Pay | |
| 2022 | Japan Approves Genscript Biotech's Chimeric Antigen Receptor T Cell Therapy | |
| 2022 | Genscript Bio's H1 Loss Widens on Higher Fair Value Losses | |
| 2022 | GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreak.. | |
| 2022 | GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Proce.. | |
| 2022 | Genscript Biotech Unit to Hold Research and Development Day in New York; Shares Slip 5% | |
| 2022 | Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30,.. | |
| 2022 | GenScript USA Responds to Monkeypox Public-Health Emergency with Real-Time PCR Test | |
| 2022 | GenScript Launches Expedited mRNA Service for Research and Pre-Clinical Applications | |
| 2022 | GenScript Biotech Sees Up to $137 Million H1 Net Loss | |
| 2022 | Genscript Biotech Corporation Provides Earnings Guidance for the Six Months Ended June .. | |
| 2022 | Genscript Biotech Corporation Announces Board Changes | |
| 2022 | Genscript Biotech Unit Completes Follow-On Offering | |
| 2022 | Genscript Bio's Nasdaq-listed Unit Prices Stock Offering to Raise $350 Million | |
| 2022 | GenScript to Host 2nd Annual Gene & Cell Engineering Virtual Summit | |
| 2022 | Genscript Biotech's Nasdaq-listed Unit Plans $250 Million Stock Offering | |
| 2022 | Genscript Biotech Unit Logs $24 Million in Q2 Sales of Immunotherapy; Shares Slip 3% | |
| 2022 | GenScript Biotech Unit Terminates Phase 1 Study for Lymphoma Therapy; Shares Down 3% | |
| 2022 | Genscript Biotech Unit Completes $37 Million Sale of Series B Shares | |
| 2022 | Genscript Biotech Unit Presents Updated Study Results of Cancer Therapy at US Oncology .. | |
| 2022 | GenScript USA Enters Distribution Agreement with EUROIMMUN US for cPass SARS-CoV-2 Neut.. | |
| 2022 | Genscript Biotech Corporation Signs A Memorandum of Understanding with Singapore Instit.. | |
| 2022 | Genscript Biotech's Nasdaq-listed Unit Promotes Finance VP to CFO; Shares Slip 5% | |
| 2022 | Chinese Prosecutors Won't File Smuggling Charges Against Genscript Biotech; Shares Slip.. | |
| 2022 | Genscript Biotech Corporation Announces Board Changes | |
| 2022 | Genscript Biotech Unit Receives $50 Million Milestone Payment from Janssen Biotech | |
| 2022 | GenScript Debuts Industry's Highest Throughput DNA Synthesis Platform for Commercial DN.. | |
| 2022 | Genscript Biotech Widens Loss on Higher R&D Expenses in 2021 | |
| 2022 | Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December.. | |
| 2022 | Genscript Biotech's Nasdaq-Listed Unit Secures Supply Deal for Cancer Drug With Janssen.. | |
| 2022 | US FDA Approves Genscript Biotech's Immunotherapy for Myeloma | |
| 2022 | Genscript Biotech's Nasdaq-Listed Arm Sees up to $397.4 Million Loss in 2021 | |
| 2022 | Baidu, Others Poised to Join Hang Seng Index Amid Reshuffle, Analysts Say | |
| 2022 | Genscript Biotech Corporation Provides Earnings Guidance for the Year Ended 31 December.. | |
| 2022 | Legend Biotech Expects to Show Adjusted Loss for Full-Year 2021 | |
| 2022 | US FDA Suspends Clinical Trial of Genscript Biotech's Nasdaq-Listed Arm for Lymphoma Tr.. | |
| 2022 | Genscript Biotech Shells Out $50 Million in Milestone Payments to Janssen Biotech; Shar.. | |
| 2022 | Genscript Biotech Awards Restricted Shares to CEO | |
| 2021 | Nasdaq-listed Legend Biotech Raises $345 Million in Share Offering | |
| 2021 | Genscript Biotech Subscribes for $90 Million Shares in Legend Bio's ADS Public Offering.. | |
| 2021 | GenScript Biotech Corp. Expands to the United Kingdom with New Offices and Logistics Ce.. | |
| 2021 | North American Morning Briefing:Stocks Seen on Hold as F.. | |
| 2021 | Hong Kong-Listed Chinese Biotech Stocks Slide on U.S. Sanction Fears | |
| 2021 | Nasdaq-listed Legend Biotech Plans $300 Million in Stock Offering; Parent Genscript Sha.. | |
| 2021 | Genscript Biotech's Nasdaq-Listed Arm Presents Clinical Trial Data for Investigational .. | |
| 2021 | Partner of Genscript's Nasdaq-Listed Arm Submits New Drug Application for Multiple Myel.. | |
| 2021 | Genscript Biotech : Launches Closed-End Double-Stranded DNA Service for CRISPR | |
| 2021 | Genscript Biotech's Nasdaq-listed Unit Widens Loss in Q3; Shares Soar 4% | |
| 2021 | GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR | |
| 2021 | Genscript Launches Closed-End Double-Stranded DNA Service for CRISPR | |
| 2021 | Genscript's Nasdaq-Listed Arm to Present 12 Sponsored Studies at American Society of He.. | |
| 2021 | US FDA Extends Approval Target Date for Genscript Biotech's Myeloma Drug; Shares Fall 8.. | |
| 2021 | Genscript Biotech : Unit Signs Deal for License Application, Commercia.. | |
| 2021 | Genscript Biotech : Nasdaq-listed Arm to Present Preclinical, Clinical.. | |
| 2021 | Genscript Biotech : Bio's Nasdaq-Listed Unit to Hold Inaugural R&D Day.. | |
| 2021 | Genscript Biotech : H1 Loss Narrows on 38% Revenue Growth | |
| 2021 | Genscript Biotech : Nasdaq-Listed Arm Gets Regulatory OK to Start Phas.. | |
| 2021 | Genscript Biotech : Unit Issues 300 Million Shares to Hillhouse Capita.. | |
| 2021 | Genscript Biotech : Reports First Half 2021 Results | |
| 2021 | Genscript Biotech : Reports 2021 Interim Financial Results | |
| 2021 | Genscript Biotech Corporation Reports Earnings Results for the Half Year Ended June 30,.. | |
| 2021 | Discloseable Transactions : Deemed disposal of equity interest in probio cayman | |
| 2021 | Genscript Biotech Corporation Announces Notice of Allowance for U.S. Patent Application | |
| 2021 | Genscript : to Host Gene & Cell Engineering Virtual Summit | |
| 2021 | Genscript Biotech : Bio's Nasdaq-Listed Unit Files Shelf Registration .. | |
| 2021 | Genscript Biotech : Unit Sets Up Cellular Therapy Manufacturing Facili.. | |
| 2021 | Duke-NUS Medical School and GenScript Biotech Corporation Announce Notice of Allowance .. | |
| 2021 | Genscript Biotech : Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Ap.. | |
| 2021 | Genscript Biotech : Controlling Shareholder Completes Disposal of Stak.. | |
| 2021 | Genscript Biotech : Issues 103 Million Shares to Hillhouse Capital; St.. | |
| 2021 | Hillhouse Capital Management, Ltd. completed the acquisition of 2.99% stake in Genscrip.. | |
| 2021 | Genscript : Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreeme.. | |
| 2021 | GenScript Biotech Corporation and Ligand Pharmaceuticals Incorporated Enters into Globa.. | |
| 2021 | Genscript Biotech : Grants Share Options, Restricted Shares; Shares Ra.. | |
| 2021 | Genscript Biotech's Nasdaq-listed Unit Readies to Present Study Results of Myeloma Drug.. | |
| 2021 | US FDA to Prioritize Review of Genscript Biotech's Myeloma Drug | |
| 2021 | Genscript Biotech Corporation Updates on the Investigation by the Zhenjiang Customs Ant.. | |
| 2021 | Genscript Biotech Closes Sale of $300 Milion Worth of Legend Biotech Shares to Hillhous.. | |
| 2021 | Hong Kong Stocks End Flat Ahead of Index Review Results; Genscript Biotech Gains 3% | |
| 2021 | Genscript Biotech Unit Gets $15 Million as Marketing Application for Cancer Drug Accept.. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
